182 related articles for article (PubMed ID: 7505365)
1. Pharmacology of SC-52458, an orally active, nonpeptide angiotensin AT1 receptor antagonist.
Olins GM; Corpus VM; Chen ST; McMahon EG; Palomo MA; McGraw DE; Smits GJ; Null CL; Brown MA; Bittner SE
J Cardiovasc Pharmacol; 1993 Oct; 22(4):617-25. PubMed ID: 7505365
[TBL] [Abstract][Full Text] [Related]
2. In vitro pharmacology of a nonpeptidic angiotensin II receptor antagonist, SC-51316.
Olins GM; Corpus VM; McMahon EG; Palomo MA; Schuh JR; Blehm DJ; Huang HC; Reitz DB; Manning RE; Blaine EH
J Pharmacol Exp Ther; 1992 Jun; 261(3):1037-43. PubMed ID: 1602371
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of DuP 532, a selective and noncompetitive AT1 receptor antagonist.
Wong PC; Hart SD; Chiu AT; Herblin WF; Carini DJ; Smith RD; Wexler RR; Timmermans PB
J Pharmacol Exp Ther; 1991 Nov; 259(2):861-70. PubMed ID: 1941632
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, U-97018.
Kushida H; Nomura S; Morita O; Harasawa Y; Suzuki M; Nakano M; Ozawa K; Kunihara M
J Pharmacol Exp Ther; 1995 Sep; 274(3):1042-53. PubMed ID: 7562467
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK&F 108566.
Edwards RM; Aiyar N; Ohlstein EH; Weidley EF; Griffin E; Ezekiel M; Keenan RM; Ruffolo RR; Weinstock J
J Pharmacol Exp Ther; 1992 Jan; 260(1):175-81. PubMed ID: 1309870
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological effects of GR138950, a novel angiotensin AT1 receptor antagonist.
Hilditch A; Hunt AA; Travers A; Polley J; Drew GM; Middlemiss D; Judd DB; Ross BC; Robertson MJ
J Pharmacol Exp Ther; 1995 Feb; 272(2):750-7. PubMed ID: 7853190
[TBL] [Abstract][Full Text] [Related]
7. Elucidation of the insurmountable nature of an angiotensin receptor antagonist, SC-54629.
Olins GM; Chen ST; McMahon EG; Palomo MA; Reitz DB
Mol Pharmacol; 1995 Jan; 47(1):115-20. PubMed ID: 7838120
[TBL] [Abstract][Full Text] [Related]
8. Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent.
Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
J Pharmacol Exp Ther; 1990 Feb; 252(2):726-32. PubMed ID: 2179532
[TBL] [Abstract][Full Text] [Related]
9. Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent.
Chiu AT; McCall DE; Price WA; Wong PC; Carini DJ; Duncia JV; Wexler RR; Yoo SE; Johnson AL; Timmermans PB
J Pharmacol Exp Ther; 1990 Feb; 252(2):711-8. PubMed ID: 2313596
[TBL] [Abstract][Full Text] [Related]
10. Effects of SC-52458, an angiotensin AT1 receptor antagonist, in the dog.
McMahon EG; Yang PC; Babler MA; Suleymanov OD; Palomo MA; Olins GM; Cook CS
Am J Hypertens; 1997 Jun; 10(6):671-7. PubMed ID: 9194514
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic characterization of CI-996, a new angiotensin receptor antagonist.
Keiser JA; Ryan MJ; Panek RL; Hodges JC; Sircar I
J Pharmacol Exp Ther; 1995 Mar; 272(3):963-9. PubMed ID: 7891350
[TBL] [Abstract][Full Text] [Related]
12. Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent.
Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
J Pharmacol Exp Ther; 1990 Feb; 252(2):719-25. PubMed ID: 2179531
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.
Criscione L; de Gasparo M; Bühlmayer P; Whitebread S; Ramjoué HP; Wood J
Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
[TBL] [Abstract][Full Text] [Related]
15. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2).
Wong PC; Hart SD; Zaspel AM; Chiu AT; Ardecky RJ; Smith RD; Timmermans PB
J Pharmacol Exp Ther; 1990 Nov; 255(2):584-92. PubMed ID: 2243344
[TBL] [Abstract][Full Text] [Related]
16. Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent.
Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
J Pharmacol Exp Ther; 1990 Oct; 255(1):211-7. PubMed ID: 2213556
[TBL] [Abstract][Full Text] [Related]
17. EXP063, a nonpeptide angiotensin II and beta adrenergic receptor antagonist.
Wong PC; Duncia JV; Chiu AT; Olson RE; Rominger DH; Tam SW; Timmermans PB
J Pharmacol Exp Ther; 1993 Nov; 267(2):641-7. PubMed ID: 7902431
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist.
Cazaubon C; Gougat J; Bousquet F; Guiraudou P; Gayraud R; Lacour C; Roccon A; Galindo G; Barthelemy G; Gautret B
J Pharmacol Exp Ther; 1993 May; 265(2):826-34. PubMed ID: 8496828
[TBL] [Abstract][Full Text] [Related]
19. Effects of the new angiotensin II type 1 receptor antagonist KRH-594 on several types of experimental hypertension.
Inada Y; Murakami M; Kaido K; Nakao K
Arzneimittelforschung; 1999 Jan; 49(1):13-21. PubMed ID: 10028373
[TBL] [Abstract][Full Text] [Related]
20. In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
Siegl PK; Chang RS; Mantlo NB; Chakravarty PK; Ondeyka DL; Greenlee WJ; Patchett AA; Sweet CS; Lotti VJ
J Pharmacol Exp Ther; 1992 Jul; 262(1):139-44. PubMed ID: 1625193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
